DaVita's (DVA) New Buyout to Enhance Transplant Experience

Published on January 19, 2022

DaVita (DVA) acquires MedSleuth which will help simplify the kidney transplant process and provide patients greater access to transplantation.

Continue reading on website
Other news

Here's Why You Should Retain Chemed (CHE) Stock for Now

January 19, 2022
Investors are optimistic about Chemed (CHE), given impressive performance of the Roto-Rooter arm and solid growth in VITAS admissions.

3 Lessons Leaders Can Learn From Watching the Netflix Film 'Don't Look Up'

January 19, 2022
Although it may be a satirical sci-fi movie, it has important things to say about the way we lead.